Pharmaceutical delivery systems for hydrophobic drugs and compositions comprising same
US11179402B2 · kind B2 · utility
4Cited by
60References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 15, 2017 |
| Grant date | Nov 23, 2021 |
| Priority date | — |
| Expiry date | Nov 15, 2037 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K9/1075
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A drug delivery system for oral administration of hydrophobic drugs with enhanced and extended absorption and improved pharmacokinetics is provided. In one embodiment, formulations comprising testosterone and testosterone esters, e.g., testosterone palmitate, are disclosed. Methods of treating a hormone deficiency or effecting male contraception with the inventive formulations are also provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.